Skip to main content

Table 1 Cumulative risk of breast cancer in Sweden, penetrance of BRCA1 and BRCA2 mutations based on the literature and life expectancy of Swedish women*

From: Contribution of the Defective BRCA1, BRCA2 and CHEK2 Genes to the Familial Aggregation of Breast Cancer: a Simulation Study Based on the Swedish Family-Cancer Database

 

Cumulative risk of breast cancer (%)

% alive

by age

all women

BRCA1 mutation carriers

BRCA2 mutation carriers

 

25

0.003

0.10

0.10

99.1

30

0.02

0.65

0.70

98.8

35

0.09

4.26

2.47

98.4

40

0.31

11.57

6.20

97.7

45

0.85

23.59

10.37

96.5

50

1.74

38.31

16.18

94.3

55

2.95

45.96

23.05

90.5

60

4.26

53.51

30.55

85.9

65

5.59

59.38

38.61

80.5

69

6.48

62.73

42.25

77.3

  1. *[12]; see Patients and methods for details